Open AccessInteraction Between Everolimus and Tacrolimus in Renal Transplant Recipients: A Pharmacokinetic Controlled Trial
Author(s) -
Julio Pascual,
Domingo del Castillo,
Mercedes Cabello,
Luis Pallardó,
Josep M. Grinyó,
Ana Fernández,
Merçè Brunet
Publication year - 2010
Publication title -
transplantation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.45
H-Index - 204
eISSN - 1534-6080
pISSN - 0041-1337
DOI - 10.1097/tp.0b013e3181ccd7f2
Subject(s) - cmin , medicine , pharmacokinetics , urology , tacrolimus , everolimus , bioavailability , regimen , renal function , transplantation , dose , pharmacology , area under the curve , gastroenterology , cmax
Clinical data are lacking concerning therapeutic action and systemic exposure of tacrolimus (TAC) and everolimus (EVL) in a combined regimen in renal transplantation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom